Replies to post #144036 on Innovation Pharmaceuticals Inc (IPIX)

[TheHound]

$CTIX Lead drug info, News, SEC filings, FDA trials, & misc. info:

SEC filings: http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Press Releases: http://cellceutix.com/category/press-release/

Recent News: http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX

Clinical trials: https://clinicaltrials.gov/ct2/results/displayOpt?flds=a&flds=b&flds=f&flds=c&flds=p&submit_fld_opt=on&=Update+Display&term=cellceutix&show_flds=Y

Management: http://cellceutix.com/team/

Product Pipeline: http://cellceutix.com/pipeline

When reading the iHub board posts:

B = Brilacidin, new class of antibiotic called defensin-mimetic
http://cellceutix.com/brilacidin/#sthash.YILNlO7Z.dpbs

K = Kevetrin, the oncology drug
http://cellceutix.com/kevetrin/#sthash.wHW2BJAD.dpbs

P = Prurisol, the psoriasis drug
http://cellceutix.com/prurisol/#sthash.GP0Dc7Qd.dpbs

FDA designations: 3 Orphans, 1 QIDP, 1 Fast-track and 1 Rare-Pediatric for CTIX
Orphan: Pancreatic, Ovarian, Retinoblastoma
QIDP: Brilacidin
Fast-track: Oral Mucositis (OM)
Rare-Pediatric: Retinoblastoma

Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
978.236.8717 Phone
978.921.6564 Fax
E-mail: [e-mail]

CIK: 0001355250

All of above stolen from and compiled by KarinCA